Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Shaping the BRCAness mutational landscape by alternative double-strand break repair, replication stress and mitotic aberrancies
Colin Stok, Yannick P. Kok, Nathalie van den Tempel, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 8, pp. 4239-4257
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

A pan-cancer compendium of chromosomal instability
Ruben M. Drews, Bárbara Hernando, Maxime Tarabichi, et al.
Nature (2022) Vol. 606, Iss. 7916, pp. 976-983
Open Access | Times Cited: 204
Genomic instability, inflammatory signaling and response to cancer immunotherapy
Mengting Chen, Renske Linstra, Marcel A.T.M. van Vugt
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1877, Iss. 1, pp. 188661-188661
Open Access | Times Cited: 117
DNA Damage and Its Role in Cancer Therapeutics
Jaeyoung Moon, Ichiwa Kitty, Kusuma Renata, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4741-4741
Open Access | Times Cited: 42
A glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2
Li Kong, Komal Gupta, Andy Jialun Wu, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2269-2287.e16
Open Access | Times Cited: 17
Signatures of TOP1 transcription-associated mutagenesis in cancer and germline
Martin A.M. Reijns, David Parry, Thomas Williams, et al.
Nature (2022) Vol. 602, Iss. 7898, pp. 623-631
Open Access | Times Cited: 58
Structural Variation in Cancer: Role, Prevalence, and Mechanisms
Marco Raffaele Cosenza, Bernardo Rodríguez–Martín, Jan O. Korbel
Annual Review of Genomics and Human Genetics (2022) Vol. 23, Iss. 1, pp. 123-152
Open Access | Times Cited: 43
RAD52: Paradigm of Synthetic Lethality and New Developments
Matthew J. Rossi, Sarah DiDomenico, Mikir Patel, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 42
When breaks get hot: inflammatory signaling in BRCA1/2-mutant cancers
Marcel A.T.M. van Vugt, Eileen E. Parkes
Trends in cancer (2022) Vol. 8, Iss. 3, pp. 174-189
Open Access | Times Cited: 36
USP51/PD‐L1/ITGB1‐deployed juxtacrine interaction plays a cell‐intrinsic role in promoting chemoresistant phenotypes in non‐small cell lung cancer
Jianjun Li, Xuechun Xiao, Yang Ou, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 765-787
Open Access | Times Cited: 20
Targeted thorium-227 conjugates as treatment options in oncology
Jenny Karlsson, Christoph A. Schatz, Antje M. Wengner, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 16
Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management
Akiyo Yoshimura, Issei Imoto, Hiroji Iwata
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7481-7481
Open Access | Times Cited: 26
Sister chromatid exchanges induced by perturbed replication can form independently of BRCA1, BRCA2 and RAD51
Anne Margriet Heijink, Colin Stok, David Porubský, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1/HDAC2 to control H2BK120 acetylation and homology-directed repair
Eros Di Giorgio, Emiliano Dalla, Vanessa Tolotto, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 14, pp. 8218-8240
Open Access | Times Cited: 4
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology
Irina Kerle, Thomas Groß, Anja Kögler, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Small tandem DNA duplications result from CST-guided Pol α-primase action at DNA break termini
Joost Schimmel, Núria Muñoz-Subirana, Hanneke Kool, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 31
DNA nicks induce mutational signatures associated with BRCA1 deficiency
Yi-Li Feng, Qian Liu, Ruo-Dan Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Senataxin and R-loops homeostasis: multifaced implications in carcinogenesis
Veronica Gatti, Sara De Domenico, Gerry Melino, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology
Alexander M.A. van der Wiel, Lesley Schuitmaker, Ying Cong, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4157-4157
Open Access | Times Cited: 16
Use of PARP inhibitors in prostate cancer: from specific to broader application
Zhenting Zhang, Lei Diao, Chao Zhang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Microhomology‐mediated repair machinery and its relationship with HPV‐mediated oncogenesis
Subhajit Chatterjee, Gabriel J. Starrett
Journal of Medical Virology (2024) Vol. 96, Iss. 5
Open Access | Times Cited: 3
Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis
Alhafidz Hamdan, Ailith Ewing
The Journal of Pathology (2022) Vol. 257, Iss. 4, pp. 479-493
Open Access | Times Cited: 14
Human RAD52 stimulates the RAD51-mediated homology search
Ali Akbar Muhammad, Clara Basto, Thibaut Peterlini, et al.
Life Science Alliance (2023) Vol. 7, Iss. 3, pp. e202201751-e202201751
Open Access | Times Cited: 7
Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade
Tingting Chen, Tong Yu, Shuping Zhuang, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 5, pp. 916-926
Open Access | Times Cited: 9
Processing DNA lesions during mitosis to prevent genomic instability
Anastasia Audrey, Lauren de Haan, Marcel A.T.M. van Vugt, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 4, pp. 1105-1118
Open Access | Times Cited: 9
Primary refractory plasmablastic lymphoma: A precision oncology approach
Hanno M. Witte, Anke Fähnrich, Axel Künstner, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top